Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
This study is to assess the biodistribution and kinetics of a novel T-cell imaging agent in
non-small cell lung cancer patients undergoing immunotherapy with and without adjuvant
radiation therapy. This study is assessing the change in kinetics that occurs in this patient
population to better understand the distribution of this compound in patient disease
circumstances.